Nasal Microbiota Transplant (NMT)

BIOLOGICAL3 trials

Sponsors

Johns Hopkins University

Conditions

Microbial ColonizationMicrobial TransplantNeonatal InfectionPediatric InfectionS. Aureus ColonizationStaphylococcal Aureus InfectionStaphylococcus Aureus

Phase 1

Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant

Active, not recruitingNCT05695196

Johns Hopkins UniversityMicrobial Colonization, Neonatal Infection, Staphylococcus Aureus

Start: 2023-10-25End: 2026-12-01Updated: 2025-12-11

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Active, not recruitingNCT06283355

Johns Hopkins UniversityMicrobial Colonization, Neonatal Infection, Staphylococcus Aureus

Start: 2024-09-03End: 2027-12-31Updated: 2026-09-04

Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

RecruitingNCT06805994

Johns Hopkins UniversityMicrobial Colonization, Microbial Transplant, Pediatric Infection +2

Start: 2025-08-27End: 2028-01-01Target: 175Updated: 2026-08-10